Conversely, samples from patients with slow and fast progression rates showed a trend in clustering away from each other according to the Bray–Curtis and the Weighted UniFrac metrics, although without statistical significance (PERMANOVA p = 0.061 and p = 0.588, respectively).
← all excerpts
The Gut Microbiota-Immunity Axis in ALS: A Role in Deciphering Disease Heterogeneity?
1
—
—